» Articles » PMID: 10887501

Oligosaccharides and Glycoconjugates in Human Milk: Their Role in Host Defense

Overview
Date 1996 Jul 1
PMID 10887501
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Human milk contains an extremely high concentration of complex carbohydrates, especially oligosaccharides, the third most abundant solid constituent of human milk. The value of human milk nutrients to infants is now widely recognized, and a role for the secretory antibodies of human milk in the defense of the infant is generally accepted. However, a function for nonimmunoglobulin milk protective factors, many of them non-nutrients, in providing for the defense of the nursling is only now beginning to be appreciated. Prominent among postulated defense agents are the milk oligosaccharides and glycoconjugates. Their complex carbohydrate structures are thought to be assembled by the same enzymes, the glycosyltransferases, that synthesize the cell surface glycoconjugates often used as receptors by pathogens. Some milk oligosaccharides and glycoconjugates may protect the nursing infant by acting as receptor homologs, inhibiting the binding of enteropathogens to their host receptors. Ongoing research is linking specific carbohydrate structures with protection against specific pathogens. Current information regarding the composition, protective activities, and protective mechanisms of the milk glycolipids, glycoproteins, mucins, glycosaminoglycans, and oligosaccharides is reviewed.

Citing Articles

Enzymatic Synthesis of Disialyllacto-N-Tetraose (DSLNT) and Related Human Milk Oligosaccharides Reveals Broad Siglec Recognition of the Atypical Neu5Acα2-6GlcNAc Motif.

Bao S, Shen T, Shabahang M, Bai G, Li L Angew Chem Int Ed Engl. 2024; 63(51):e202411863.

PMID: 39223086 PMC: 11631665. DOI: 10.1002/anie.202411863.


A game theory model for gut bacterial nutrient utilization strategies during human infancy.

Angell I, Rudi K Proc Biol Sci. 2020; 287(1931):20200824.

PMID: 32673553 PMC: 7423673. DOI: 10.1098/rspb.2020.0824.


Bioactive molecules of probiotic bacteria and their mechanism of action: a review.

Indira M, Venkateswarulu T, Peele K, Bobby M, Krupanidhi S 3 Biotech. 2019; 9(8):306.

PMID: 31355115 PMC: 6656846. DOI: 10.1007/s13205-019-1841-2.


Biochemical characterization of Helicobacter pylori α1-3-fucosyltransferase and its application in the synthesis of fucosylated human milk oligosaccharides.

Bai J, Wu Z, Sugiarto G, Gadi M, Yu H, Li Y Carbohydr Res. 2019; 480:1-6.

PMID: 31132553 PMC: 6613818. DOI: 10.1016/j.carres.2019.05.007.


Utilization of Host-Derived Glycans by Intestinal and Species.

Zuniga M, Monedero V, Yebra M Front Microbiol. 2018; 9:1917.

PMID: 30177920 PMC: 6109692. DOI: 10.3389/fmicb.2018.01917.


References
1.
Shimizu M, Yamauchi K, Miyauchi Y, Sakurai T, Tokugawa K, McIlhinney R . High-Mr glycoprotein profiles in human milk serum and fat-globule membrane. Biochem J. 1986; 233(3):725-30. PMC: 1153091. DOI: 10.1042/bj2330725. View

2.
Ashkenazi S, Newburg D, Cleary T . The effect of human milk on the adherence of enterohemorrhagic E. coli to rabbit intestinal cells. Adv Exp Med Biol. 1991; 310:173-7. DOI: 10.1007/978-1-4615-3838-7_21. View

3.
Stoll B, Holmgren J, Bardhan P, Huq I, Greenough 3rd W, Fredman P . Binding of intraluminal toxin in cholera: trial of GM1 ganglioside charcoal. Lancet. 1980; 2(8200):888-91. DOI: 10.1016/s0140-6736(80)92049-8. View

4.
Nuijens J, van Berkel P, Schanbacher F . Structure and biological actions of lactoferrin. J Mammary Gland Biol Neoplasia. 1996; 1(3):285-95. DOI: 10.1007/BF02018081. View

5.
Telemo E, Hanson L . Antibodies in milk. J Mammary Gland Biol Neoplasia. 1996; 1(3):243-9. DOI: 10.1007/BF02018077. View